MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,935,770 | +56.6% | 67,396 | +33.6% | 0.01% | +57.1% |
Q1 2023 | $1,875,136 | +53.3% | 50,434 | +86.9% | 0.01% | +40.0% |
Q4 2022 | $1,222,826 | -44.0% | 26,988 | -13.6% | 0.01% | -44.4% |
Q3 2022 | $2,182,000 | -9.3% | 31,243 | -12.9% | 0.01% | 0.0% |
Q2 2022 | $2,407,000 | +4.2% | 35,860 | +27.7% | 0.01% | +28.6% |
Q1 2022 | $2,310,000 | -35.4% | 28,091 | +15.3% | 0.01% | -30.0% |
Q4 2021 | $3,574,000 | -18.9% | 24,366 | -2.2% | 0.01% | -28.6% |
Q3 2021 | $4,405,000 | +20.1% | 24,902 | +9.7% | 0.01% | +16.7% |
Q2 2021 | $3,668,000 | -3.9% | 22,710 | +1.9% | 0.01% | -7.7% |
Q1 2021 | $3,816,000 | -8.2% | 22,277 | +17.7% | 0.01% | -13.3% |
Q4 2020 | $4,157,000 | +23.6% | 18,928 | -6.5% | 0.02% | +15.4% |
Q3 2020 | $3,362,000 | +41.9% | 20,248 | -2.5% | 0.01% | +30.0% |
Q2 2020 | $2,370,000 | +36.0% | 20,759 | -8.5% | 0.01% | +25.0% |
Q1 2020 | $1,743,000 | -40.4% | 22,681 | 0.0% | 0.01% | -27.3% |
Q4 2019 | $2,923,000 | +72.9% | 22,681 | +4.5% | 0.01% | +57.1% |
Q3 2019 | $1,691,000 | – | 21,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |